methylprednisolone acetate has been researched along with Cochlear Hearing Loss in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Hennawi, DM | 1 |
| El-Deen, MH | 1 |
| Abou-Halawa, AS | 1 |
| Nadeem, HS | 1 |
| Ahmed, MR | 1 |
1 other study available for methylprednisolone acetate and Cochlear Hearing Loss
| Article | Year |
|---|---|
Efficacy of intratympanic methylprednisolone acetate in treatment of drill-induced sensorineural hearing loss in guinea pigs.
Topics: Animals; Anti-Inflammatory Agents; Cochlea; Drug Administration Routes; Drug Evaluation, Preclinical | 2005 |